Treatment of inflammatory bowel disease

被引：2

作者：

Nikolaus, S. ^{[1
]}

Schreiber, S. ^{[1
]}

机构：

[1] Univ Klinikum Schleswig Holstein, Klin Innere Med 1, D-24105 Kiel, Germany

来源：

DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT | 2013年 / 138卷 / 05期

关键词：

inflammatory bowel disease; Crohn's disease; ulcerative colitis; biologicals; CROHNS-DISEASE; ULCERATIVE-COLITIS; CLINICAL-COURSE; INFLIXIMAB; ADALIMUMAB; TRIAL; IBSEN;

D O I：

10.1055/s-0032-1327429

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：205 / 208

页数：4

共 14 条

[1] Noncolorectal Malignancies in Inflammatory Bowel Disease: More than Meets the Eye [J].

Beaugerie, Laurent ;

Sokol, Harry ;

Seksik, Philippe .

DIGESTIVE DISEASES, 2009, 27 (03) :375-381

[2] Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease. [J].

Colombel, Jean Frederic ;

Sandborn, William J. ;

Reinisch, Walter ;

Mantzaris, Gerassimos J. ;

Kornbluth, Asher ;

Rachmilewitz, Daniel ;

Lichtiger, Simon ;

D'Haens, Geert ;

Diamond, Robert H. ;

Broussard, Delma L. ;

Tang, Kezhen L. ;

van der Woude, C. Janneke ;

Rutgeerts, Paul .

NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (15) :1383-1395

[3] Long-term evolution of disease behavior of Crohn's disease [J].

Cosnes, J ;

Cattan, S ;

Blain, A ;

Beaugerie, L ;

Carbonnel, F ;

Parc, R ;

Gendre, JP .

INFLAMMATORY BOWEL DISEASES, 2002, 8 (04) :244-250

[4] Review article: the data supporting a role for aminosalicylates in the chemoprevention of colorectal cancer in patients with inflammatory bowel disease [J].

Eaden, J .

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2003, 18 :15-21

[5] Clinical course in Crohn's disease: Results of a five-year population-based follow-up study (the IBSEN study) [J].

Henriksen, Magne ;

Jahnsen, Jorgen ;

Lygren, Idar ;

Aadland, Erling ;

Schulz, Tom ;

Vatn, Morten H. ;

Moum, Bjorn .

SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2007, 42 (05) :602-610

[6] Ulcerative colitis and clinical course: Results of a 5-year population-based follow-up study (The IBSEN study) [J].

Henriksen, Magne ;

Jahnsen, Jorgen ;

Lygren, Idar ;

Sauar, Jostein ;

Kjellevold, Oystein ;

Schulz, Tom ;

Vatn, Morten H. ;

Moum, Bjorn .

INFLAMMATORY BOWEL DISEASES, 2006, 12 (07) :543-550

[7] Infliximab maintenance treatment reduces hospitalizations, surgeries, and procedures in fistulizing Crohn's disease [J].

Lichtenstein, GR ;

Yan, SK ;

Bala, M ;

Blank, M ;

Sands, BE .

GASTROENTEROLOGY, 2005, 128 (04) :862-869

[8] Vedolizumab for the treatment of active ulcerative colitis: A randomized controlled phase 2 dose-ranging study [J].

Parikh, Asit ;

Leach, Timothy ;

Wyant, Tim ;

Scholz, Catherine ;

Sankoh, Serap ;

Mould, Diane R. ;

Ponich, Terry ;

Fox, Irving ;

Feagan, Brian G. .

INFLAMMATORY BOWEL DISEASES, 2012, 18 (08) :1470-1479

[9] Influence of Phenotype at Diagnosis and of Other Potential Prognostic Factors on the Course of Inflammatory Bowel Disease [J].

Romberg-Camps, M. J. L. ;

Dagnelie, P. C. ;

Kester, A. D. M. ;

Hesselink-van de Kruijs, M. A. M. ;

Cilissen, M. ;

Engels, L. G. J. B. ;

Van Deursen, C. ;

Hameeteman, W. H. A. ;

Wolters, F. L. ;

Russel, M. G. V. M. ;

Stockbrugger, R. W. .

AMERICAN JOURNAL OF GASTROENTEROLOGY, 2009, 104 (02) :371-383

[10] Adalimumab Induces and Maintains Mucosal Healing in Patients With Crohn's Disease: Data From the EXTEND Trial [J].

Rutgeerts, Paul ;

Van Assche, Gert ;

Sandborn, William J. ;

Wolf, Douglas C. ;

Geboes, Karel ;

Colombel, Jean-Frederic ;

Reinisch, Walter ;

Kumar, Ashish ;

Lazar, Andreas ;

Camez, Anne ;

Lomax, Kathleen G. ;

Pollack, Paul F. ;

D'Haens, Geert .

GASTROENTEROLOGY, 2012, 142 (05) :1102-+

← 1 2 →